Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hallgeir Rui

Showing results (31-40 of 138) with videos related to

Pageof 14
Sort By:
Oncology Letters|August 10, 2017
Pathologic evaluation of tumor-associated macrophage density and vessel inflammation in invasive breast carcinomasYoshihiro Morita, Roy Zhang, Macall Leslie, et al.
Breast Cancer Research : BCR|December 30, 2024
Surgical delay-associated mortality risk varies by subtype in loco-regional breast cancer patients in SEER-MedicareMacall Leslie Salewon, Rashmi Pathak, William C Dooley, et al.
Cancer Research|November 1, 2011
Cyclin D3 compensates for the loss of cyclin D1 during ErbB2-induced mammary tumor initiation and progressionQian Zhang, Kazuhito Sakamoto, Chengbao Liu, et al.
Molecular and Cellular Biology|June 1, 2004
Impaired alveologenesis and maintenance of secretory mammary epithelial cells in Jak2 conditional knockout miceKay-Uwe Wagner, Andrea Krempler, Aleata A Triplett, et al.
Cancer Research|March 5, 2008
Oncogene-mediated inhibition of glycogen synthase kinase 3 beta impairs degradation of prolactin receptorAlexander Plotnikov, Ying Li, Thai H Tran, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2004
Signal transducer and activator of transcription-5 activation and breast cancer prognosisMarja T Nevalainen, Jianwu Xie, Joachim Torhorst, et al.
Annals of Surgical Oncology|March 5, 2021
ASO Author Reflections: Does Prompt Breast-Conserving Surgery Matter?Natalie Hills, Macall Leslie, Rachel Davis, et al.
Annals of Surgical Oncology|March 22, 2021
Prolonged Time from Diagnosis to Breast-Conserving Surgery is Associated with Upstaging in Hormone Receptor-Positive Invasive Ductal Breast CarcinomaNatalie Hills, Macall Leslie, Rachel Davis, et al.
Cell Cycle (Georgetown, Tex.)|October 16, 2010
RB-pathway disruption in breast cancer: differential association with disease subtypes, disease-specific prognosis and therapeutic responseAdam Ertel, Jeffry L Dean, Hallgeir Rui, et al.
The Journal of Endocrinology|July 29, 2009
Ovarian hormones are not required for PRL-induced mammary tumorigenesis, but estrogen enhances neoplastic processesLisa M Arendt, Lindsay C Evans, Debra E Rugowski, et al.
Pageof 14

Showing results (31-40 of 138) with videos related to

Sort By:
Pageof 14
Oncology Letters|August 10, 2017
Pathologic evaluation of tumor-associated macrophage density and vessel inflammation in invasive breast carcinomasYoshihiro Morita, Roy Zhang, Macall Leslie, et al.
Breast Cancer Research : BCR|December 30, 2024
Surgical delay-associated mortality risk varies by subtype in loco-regional breast cancer patients in SEER-MedicareMacall Leslie Salewon, Rashmi Pathak, William C Dooley, et al.
Cancer Research|November 1, 2011
Cyclin D3 compensates for the loss of cyclin D1 during ErbB2-induced mammary tumor initiation and progressionQian Zhang, Kazuhito Sakamoto, Chengbao Liu, et al.
Molecular and Cellular Biology|June 1, 2004
Impaired alveologenesis and maintenance of secretory mammary epithelial cells in Jak2 conditional knockout miceKay-Uwe Wagner, Andrea Krempler, Aleata A Triplett, et al.
Cancer Research|March 5, 2008
Oncogene-mediated inhibition of glycogen synthase kinase 3 beta impairs degradation of prolactin receptorAlexander Plotnikov, Ying Li, Thai H Tran, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2004
Signal transducer and activator of transcription-5 activation and breast cancer prognosisMarja T Nevalainen, Jianwu Xie, Joachim Torhorst, et al.
Annals of Surgical Oncology|March 5, 2021
ASO Author Reflections: Does Prompt Breast-Conserving Surgery Matter?Natalie Hills, Macall Leslie, Rachel Davis, et al.
Annals of Surgical Oncology|March 22, 2021
Prolonged Time from Diagnosis to Breast-Conserving Surgery is Associated with Upstaging in Hormone Receptor-Positive Invasive Ductal Breast CarcinomaNatalie Hills, Macall Leslie, Rachel Davis, et al.
Cell Cycle (Georgetown, Tex.)|October 16, 2010
RB-pathway disruption in breast cancer: differential association with disease subtypes, disease-specific prognosis and therapeutic responseAdam Ertel, Jeffry L Dean, Hallgeir Rui, et al.
The Journal of Endocrinology|July 29, 2009
Ovarian hormones are not required for PRL-induced mammary tumorigenesis, but estrogen enhances neoplastic processesLisa M Arendt, Lindsay C Evans, Debra E Rugowski, et al.
Pageof 14